跳至主要内容
临床试验/NCT03614507
NCT03614507终止不适用

Automation Oxygen Flow Titration in Spontaneously Breathing Infants Less Than One Year of Age During a First Episode of Bronchiolitis

University Hospital, Brest20 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2018年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
105
试验地点
20
主要终点
Length of hospital stay in hours since the admission to the emergency room.

研究概览

简要总结

The objective of this study is to assess the efficacy of the FreeO2 device in shortening the hospital length of stay during a first episode of hypoxemic bronchiolitis in infants less than 1 year of age.

FreeO2Bronchio study is a multicenter, prospective, controlled, randomized, open-label study.

详细描述

This is a controlled, randomized, open-label, multicentre trial. Patients will be included after written informed consent will be obtained from the patients' parents or legally authorized representatives. Patients will be randomized either in the "FreeO2" group for automatic oxygen flow titration or in the "manual" group for Oxygen therapy with manual flow titration. The SpO2 will be recorded continuously in both groups of the study using the FreeO2 device throughout the duration of hospitalization; In the group "FreeO2 ", the device will record the data continuously and allow the automation of oxygen titration - in the group "Manual", the device will only be used to monitor SpO2 and heart rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

The technology used does not allow blinding.

入排标准

年龄范围
1 Month 至 1 Year(Child)
性别
All
接受健康志愿者

入选标准

  • Infants from 1 month of age and less than 1 year of age who present a first episode of bronchiolitis and require oxygen therapy
  • Informed consent of parents (written informed consent will be obtained from the patients' parents or legally authorized representatives)
  • Affiliation to the French social security system

排除标准

  • Need for oxygen flow higher than 3 L / min to maintain SpO2 greater than 92%
  • Patient with severity criteria according to the 2019 French National Authority for Health (HAS) guidelines and for whom it's indicated to maintain SpO2 above 94%
  • Criteria of severity justifying from the start another technique of assisted ventilation:
  • Polypnea: respiratory rate (FR)> 80 c / min.
  • Consciousness with glasgow score (GSC) <or =
  • Hemodynamic instability (mean arterial pressure (MAP) <- 2 SD for age or use of vasopressors).
  • Cardiac or respiratory arrest.
  • PCO2> 55 mm Hg and pH <7.20 when blood gas are performed
  • Need for urgent surgery
  • Contraindication to the FreeO2 device as described in the user manual
  • Lack of informed consent from parents
  • Premature birth with a gestational age at birth under 36 weeks
  • Severe co-morbidities (cystic fibrosis, immune deficiency, congenital heart disease, neuromuscular illness)

结局指标

主要结局

Length of hospital stay in hours since the admission to the emergency room.

时间窗: 30 days max

The length of hospital stay in hours since admission in the emergency room will be compared between the two groups.

次要结局

  • Number of patients readmited to hospital within 7 days and 30 days following discharge(30 days max)
  • Duration of enteral feeding (hours)(30 days max)
  • Duration of intravenous hydration (hours)(30 days max)
  • Number of patient admitted to the intensive care unit within 3 days following the hospital admission(30 days max)
  • Number of patients needing Heated Humidified High Flow Nasal Cannula (HFNNC)(30 days max)
  • Number of patients needing assisted ventilation (invasive or noninvasive )(30 days max)
  • Number of reported Adverse Events(30 days max)
  • Time spent in the a area of severe desaturation (SpO2 <92%) and of hyperoxia area (SpO2> 98%).(30 days max)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验

Automation Oxygen Flow Titration in Spontaneously... | 临床试验